NASA working with Cleveland health system on COVID response

Decontaminating PPE for frontline healthcare workers—and potentially astronauts—is the mission as the National Aeronautics and Space Administration tests two new ways to sanitize reusable masks during the coronavirus pandemic.

The agency is working on the project with University Hospitals in Cleveland.

NASA’s Glenn Research Center, which is based in the same city, announced the development June 30.

The experimental approaches use atomic oxygen, which is created by heating ozone in a chamber, and peracetic acid, a chemical disinfectant widely used in other applications.

“NASA strives to ensure the technology we develop for space exploration and aeronautics is broadly available to benefit the public and the nation,” says Glenn Center Director Marla Pérez-Davis, PhD. “If our technology can lend a hand in overcoming this crisis, we will do whatever we can to put it in the hands of those who need it.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.